CompletedNot Applicable

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

United States200 participantsStarted 2019-05-01

Plain-language summary

The investigators will prospectively evaluate for the presence of amyloid deposits in ligamentum flavum (yellow ligament) tissue samples obtained from patients undergoing spinal stenosis surgery. Patients who have tissue that stains positive for amyloid will be referred to an amyloidosis specialist.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥50 years * Undergoing surgical intervention for non-congenital spinal stenosis and/or spondyloarthropathy * Able to consent Exclusion Criteria: * History of congenital spinal stenosis or congenital spondyloarthropathy

What they're measuring

Incidence of amyloidosis in older patients undergoing spinal stenosis surgery

Timeframe: Baseline to 30 days

Trial details

NCT IDNCT03923920

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-10-04

View on ClinicalTrials.gov More Amyloid trials